Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The consultant episode: an unhelpful measure.

Authors: J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal: Gut Date: 2007-02 Impact factor: 23.059

The consultant episode: an unhelpful measure.

1. Can readmission rates be used as an outcome indicator?

2. Are readmissions avoidable?

3. The impact of DRG reimbursement on strategic planning.

4. Measuring readmission rates.

Review 5. How will diagnosis-related groups affect epidemiologic research?

6. Trends in episode based and person based rates of admission to hospital in the Oxford record linkage study area.

7. Ophthalmology in the Oxford region: analysis of time trends from linked statistics.

8. The effect of prospective payment on Medicare expenditures.

9. Purpose of admission and resource use during cancer hospitalizations.

1. Number of cases operated on is important in volume-outcome debate for colorectal cancer.

2. Informing the market: the strengths and weaknesses of information in the British National Health Service.

3. Rationing health care: from needs to markets? The politics of destruction: rationing in the UK health care market.

Review 4. Purchasing for quality: still in the starting blocks?

5. Routine data: a resource for clinical audit?

Review 6. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

7. Challenges of monitoring use of secondary care at local level: a study based in London, UK.

8. Measuring hospital performance: are we asking the right questions?

9. Consultant episodes.

10. Trends in colorectal cancer care in southern England, 1989-1993: using HES data to inform cancer services reviews.